Orphazyme A/S buy Amped
Start price
21.06.21
/
0%
€6.55
Target price
21.06.22
-
Performance (%)
-3.82%
End price
21.06.21
€6.30
Summary
This prediction ended on 21.06.21 with a price of €6.30. With a performance of -3.82%, the BUY prediction by Amped finished with a loss. This prediction was marked as speculative and is excluded from Amped's performance statistics.Performance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Orphazyme A/S | - | - | - | - |
iShares Core DAX® | 2.291% | 2.984% | 20.344% | 20.143% |
iShares Nasdaq 100 | 1.336% | -0.196% | 25.550% | 37.734% |
iShares Nikkei 225® | 1.132% | 2.488% | 13.163% | 1.261% |
iShares S&P 500 | 1.272% | 1.334% | 24.544% | 40.521% |
According to Amped what are the pros and cons of Orphazyme A/S for the foreseeable future?
Pros
EBIT growth >5% per year expected
Capable Management
Known brand
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Fair valuation
Good culture
Sustainability is important
Top 10 in its market
Very Future proof/growth oriented business model
Cons
Few uniques
Dependend from some customers or products
Significant cyclical dependencies
Comments by Amped for this prediction
In the thread Orphazyme A/s diskutieren
Buy Orphazyme A/S
In the thread Trading Orphazyme A/s
Buy beendet
Stopped prediction by Amped for Orphazyme A/S
Orphazyme A/S
Start price
Target price
Perf. (%)
€6.80
25.06.21
25.06.21
-
21.06.22
21.06.22
-88.60%
22.06.22
22.06.22
EBIT growth >5% per year expected
Capable Management
Few uniques
Dependend from some customers or products
Orphazyme A/S
Start price
Target price
Perf. (%)
€0.78
25.06.21
25.06.21
-
21.06.22
21.06.22
-
25.06.21
25.06.21
EBIT growth >5% per year expected
Capable Management
Few uniques
Dependend from some customers or products
Orphazyme A/S
Start price
Target price
Perf. (%)
€6.90
23.06.21
23.06.21
-
21.06.22
21.06.22
-1.45%
25.06.21
25.06.21
EBIT growth >5% per year expected
Capable Management
Few uniques
Dependend from some customers or products
Orphazyme A/S
Start price
Target price
Perf. (%)
€6.30
21.06.21
21.06.21
-
21.06.22
21.06.22
9.52%
23.06.21
23.06.21
EBIT growth >5% per year expected
Capable Management
Few uniques
Dependend from some customers or products